Peptides, Silicon Valley, and the Rise of "Pharma 2.0"

> This article summarizes and credits reporting from the Good Work YouTube channel's video on peptides, hosted by Dan Toomey. All quotes, interview material, and on the ground reporting featured here are drawn from that video. We strongly recommend watching the original for full context.

Peptides have moved from bodybuilding gyms and Silicon Valley group chats into the broader cultural conversation, and the Good Work YouTube channel recently took a thorough look at what they actually are, who is using them, and whether any of this is a good idea. Here is a summary of the key takeaways.

What Peptides Actually Are

As Good Work explains, peptides are short chains of amino acids that help the body perform a range of functions, from healing muscle tears to growing skin cells to producing hormones like testosterone. The body manufactures many peptides naturally from dietary protein. Familiar examples include insulin and oxytocin.

The "peptides" that have become a cultural flashpoint are different. These are synthetic versions made in labs and injected directly into the body. The most well known are GLP-1 drugs like Ozempic and Wegovy, which are FDA approved and prescribed for weight loss and diabetes. The popularity of GLP-1s has fueled a wider search for other injectable peptides that might deliver other health benefits.

The Long, Confusing List

According to Good Work, peptide users often talk about compounds like BPC-157 (claimed to repair muscle), GHK-Cu (claimed to reduce wrinkles), Dihexa (claimed to improve focus), and Ipamorelin (claimed to improve sleep). Some users mix several into "stacks," sometimes branded with marketing friendly names like the "Wolverine Stack" or the "Glow Stack."

Most of these compounds are not FDA approved for the uses being promoted. The FDA has flagged some peptides as potentially harmful. Because of social media moderation, influencers often refer to them as "peppers" online.

The Chinese Supply Chain

Good Work's reporting describes how most non FDA approved peptides reach American users. Reporter Ezra Marcus, featured in the video, recounts going on the Peptides subreddit, getting invited to a Discord, and finding a representative from a Chinese manufacturer selling directly to users. He purchased ten vials of Retatrutide for about $150 in Bitcoin. The shipment arrived two weeks later, labeled "for research purposes only."

Independent reporter Jasmine Sun, who has written about the trend for The New York Times, told Good Work that peptides emerged as a viral San Francisco meme around mid 2025. In tech culture, she says, having a "Chinese peptide dealer" became a status symbol alongside coding agents and Waymos. The framing was about being an early adopter willing to accept some risk to get an edge.

The economics are striking. Good Work reports that a vial that retails for around $200 through middlemen often costs about $15 to manufacture in China. By Marcus's estimate, billions of dollars are being made flipping these compounds to American consumers.

Why People Are Trying Them

The video features Tori Pastore, founder of the marketing consultancy "soup," who has hosted a peptide themed rave in San Francisco. She tells Good Work that she turned to unregulated peptides after her insurance refused to cover Ozempic because her BMI was 34.7 rather than the required 35. A friend started sourcing from Chinese labs and using himself as a test subject before sharing with others.

Pastore describes serious early side effects, including months of vomiting, but says the trade off was worth it. She has also experimented with copper peptides, which she stopped after a month due to copper toxicity concerns.

Max Marchione, co founder of the health startup Superpower, is more bullish. He tells Good Work he believes peptides could become a $1 trillion category and frames the trend as "Pharma 2.0." He also acknowledges the risks and says he does not recommend that people blindly order peptides from "research use only" sites online.

The Skeptical View

Good Work also features Eric Topol, cardiologist and director of the Scripps Research Translational Institute. Topol is sharply critical of the unregulated peptide market. His core point, as he tells Good Work: there are no real clinical trials supporting most of these uses, and word of mouth, longevity clinic promotion, and influencer testimonials are not science. Without controlled trials, users cannot know whether their results are real, placebo driven, or masking harm. He emphasizes that any injectable drug should be proven safe, accurate to its label, and effective before patients use it.

Why This Matters Beyond Silicon Valley

Reporter Jasmine Sun observes in the video that what makes peptides notable is not just the tech crowd but the breadth of people now interested. With declining trust in the American medical establishment, many consumers see influencer recommendations and direct to consumer biohacking as a reasonable alternative path, especially when traditional care is too expensive or gatekept.

That cultural shift is one of the most important parts of the story. Peptides are a test case for whether a Silicon Valley early adopter habit will bleed into the mainstream the way GLP-1s did.

What This Means If You Are Considering Peptides

Drawing the takeaways from the Good Work piece: the legal, FDA approved peptide drugs like the GLP-1s have decades of clinical data behind them, while most other peptides being marketed on social media do not. The supply chain for unregulated peptides runs largely through Chinese labs, with quality control that ranges from inconsistent to nonexistent. The financial incentives for sellers and influencers are enormous, which should temper how much weight you give to enthusiastic testimonials. Even users who say peptides have transformed their lives report side effects that ranged from unpleasant to publicly embarrassing. Mainstream experts like Eric Topol argue that without clinical trials, every reported benefit is anecdote, not science.

The Bottom Line

If you are thinking about peptides, the most useful starting point is the original Good Work video, which lays out the cultural, scientific, and economic forces at play more vividly than any summary can. From there, the responsible next step is a conversation with a qualified physician, not a Discord moderator.

For testosterone replacement therapy specifically, which is FDA regulated and clinically studied, you can find vetted providers through our TRT Locator directory.

Frequently Asked Questions

Are peptides the same as testosterone or TRT?

No. Testosterone replacement therapy is an FDA-regulated, clinically studied treatment for documented hypogonadism. Most peptides being discussed in biohacking communities are either unregulated, not FDA-approved for the uses being promoted, or approved for narrow indications like diabetes and weight loss (GLP-1s). They are different categories of compounds with very different regulatory and evidence profiles.

Are peptides legal in the United States?

It depends on the compound. GLP-1 drugs like Ozempic and Wegovy are legal and FDA-approved. Many other peptides — including BPC-157, Ipamorelin, and Dihexa — are not FDA-approved for human use and are sold legally only as research chemicals, typically labeled "not for human consumption." Purchasing and using them for personal use exists in a regulatory gray area, and some have been explicitly flagged by the FDA as potentially harmful.

Where do most unregulated peptides come from?

As reporting from the Good Work YouTube channel describes, most non-FDA-approved peptides reaching American consumers are manufactured in China and sold through online platforms, Discord communities, and subreddits. Vials that retail for around $200 through middlemen often cost $15 to manufacture. Quality control ranges from inconsistent to nonexistent.

What are the most commonly discussed peptides in biohacking communities?

The most frequently mentioned compounds include BPC-157 (claimed to aid muscle repair), GHK-Cu (claimed to reduce wrinkles), Ipamorelin (claimed to improve sleep and growth hormone output), Dihexa (claimed to improve cognition), and Retatrutide (a next-generation GLP-1 compound). Users often combine these into "stacks" with marketing names.

How are peptides different from anabolic steroids?

Peptides are short chains of amino acids that signal the body to produce hormones or carry out specific functions. Anabolic steroids are synthetic derivatives of testosterone that directly act on androgen receptors to promote muscle growth. They are chemically unrelated, though both are used in performance and body optimization contexts. Neither unregulated peptides nor anabolic steroids have the clinical safety and efficacy backing of FDA-approved TRT.

Source

This article is a summary and interpretation of reporting from the Good Work YouTube channel. All factual claims, quotes, and interview material come from the original video. Full credit to the Good Work team, host Dan Toomey, and the interview subjects (Ezra Marcus, Jasmine Sun, Tori Pastore, Max Marchione, and Eric Topol) for their reporting.

• Good Work: "Peptides" (YouTube)

Find a TRT clinic near you →